Disease/Infection News

RSS

Unlocking coronavirus structure through M protein research

For centuries, coronaviruses have triggered health crises and economic challenges, with SARS-CoV-2, the coronavirus that spreads COVID-19, being a recent example.

28 Feb 2024

Scientists uncover a new doorway for SARS-CoV-2 into human cells

Research identifies the human transferrin receptor as an alternative pathway for SARS-CoV-2 infection, offering potential new targets for COVID-19 therapies.

27 Feb 2024

Harnessing artificial intelligence for infectious disease prevention

A new research review to be given at a pre-congress day for this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will look at the many ways artificial intelligence can help prevent infectious disease outbreaks including ensuring staff wear personal protective equipment correctly and managing day-to-day hospital activities such as medication prescription and cleaning.

27 Feb 2024

Harnessing artificial intelligence to enhance infectious disease outbreak investigations

A new research review to be given at a pre-congress day for this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will highlight the potential artificial intelligence (AI) has to improve the speed and accuracy of investigations into infectious disease outbreaks in hospitals, and potentially provide real time information to stop or prevent them.

27 Feb 2024

Study shows the benefits of locally administered intranasal live-attenuated SARS-CoV-2 vaccine

Rocketvax AG, together with the German Research Foundation (DFG), has financially supported a study carried out as part of a joint project of the Swiss National Science Foundation (SNSF, National Research Program "Covid-19," NRP 78) and the German Research Foundation (DFG) "Recoding the SARS-CoV-2 Genome - A Multidisciplinary Approach to Generate Live-Attenuated Coronavirus Vaccines."

27 Feb 2024

Innovative Subak tool offers affordable solution for detecting nuclease digestion

A new tool could reduce costs for diagnosing infectious diseases.

27 Feb 2024

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO Centers in Haiti.

27 Feb 2024

Ancient Eastern Arabians developed malaria resistance through agriculture, study finds

People living in ancient Eastern Arabia appear to have developed resistance to malaria following the appearance of agriculture in the region around five thousand years ago, a new study reveals.

27 Feb 2024

Flavonol-rich diet linked to lower mortality and disease risk, study shows

Study finds that higher dietary intake of flavonol is linked to reduced all-cause mortality and lower risk of Alzheimer's disease, cancer, and cardiovascular disease in US adults.

26 Feb 2024

Vaping increases susceptibility to COVID-19 infection, study finds

Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a University of California, Riverside, study has found.

26 Feb 2024

Study reveals BCG vaccine's unexpected role in fighting influenza

As Canada's flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses.

26 Feb 2024

Structural study identifies target for broad-spectrum antivirals against herpesviruses

Human herpesviruses comprise the alpha, beta, and gamma subfamilies and are a widely prevalent group of DNA-enveloped viruses, capable of establishing lifelong latent infections in humans and causing various diseases.

26 Feb 2024

Study reveals how long COVID can affect brain function through vascular disruption

The neurological response to coronavirus disease 2019 (COVID-19) may be due to brain-brain barrier (BBB) disruption.

26 Feb 2024

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.

24 Feb 2024

Global health boost as new vaccine SKYTyphoid gains WHO prequalification

SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.

23 Feb 2024

POINT project seeks to develop innovative strategies for tackling long-term COVID-19 health impact

The POINT project seeks to develop innovative strategies for the prevention and management of non-communicable diseases that arise as complications during the post-acute phase of COVID-19.

23 Feb 2024

Collaborative analysis of disease and death drivers in Gaza conflict

The analysis was conducted to help better address the humanitarian crisis in Gaza both during and after the war.

23 Feb 2024

Understanding the role played by HIV in pulmonary hypertension

Across the globe, more than 39 million people are living with the Human Immunodeficiency Virus (HIV), the virus that causes AIDS, including more than 1.3 million new HIV diagnoses last year.

23 Feb 2024

Key link discovered between spread of antibiotic resistance genes and drug resistance evolution

Biomedical engineers at Duke University have uncovered a key link between the spread of antibiotic resistance genes and the evolution of resistance to new drugs in certain pathogens.

23 Feb 2024

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

23 Feb 2024

Previous
1
...
91
92
93
94
95
96
97
...
2469
Next

Disease/Infection News

Unlocking coronavirus structure through M protein research

Scientists uncover a new doorway for SARS-CoV-2 into human cells

Harnessing artificial intelligence for infectious disease prevention

Harnessing artificial intelligence to enhance infectious disease outbreak investigations

Study shows the benefits of locally administered intranasal live-attenuated SARS-CoV-2 vaccine

Innovative Subak tool offers affordable solution for detecting nuclease digestion

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines

Ancient Eastern Arabians developed malaria resistance through agriculture, study finds

Flavonol-rich diet linked to lower mortality and disease risk, study shows

Vaping increases susceptibility to COVID-19 infection, study finds

Study reveals BCG vaccine's unexpected role in fighting influenza

Structural study identifies target for broad-spectrum antivirals against herpesviruses

Study reveals how long COVID can affect brain function through vascular disruption

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Global health boost as new vaccine SKYTyphoid gains WHO prequalification

POINT project seeks to develop innovative strategies for tackling long-term COVID-19 health impact

Collaborative analysis of disease and death drivers in Gaza conflict

Understanding the role played by HIV in pulmonary hypertension

Key link discovered between spread of antibiotic resistance genes and drug resistance evolution

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Latest News